The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.

por Hospers, G. A., de Vries, E. G., Mulder, N. H.
Publicado 1990

Modulation of cis-diamminedichloroplatinum(II) resistance: a review.

por Timmer-Bosscha, H., Mulder, N. H., de Vries, E. G.
Publicado 1992

Cisplatin in breast cancer.

por Willemse, P., Sleijfer, D. T., Mulder, N. H., de Vries, E. G.
Publicado 1993

NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinom...

por de Jong, S., Mulder, N. H., de Vries, E. G., Robillard, G. T.
Publicado 1991

Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.

por Sleijfer, S., van der Mark, T. W., Schraffordt Koops, H., Mulder, N. H.
Publicado 1995

Prolonged continuous infusion of low-dose rIL-2.

por Janssen, R. A., Buter, J., The, T. H., Mulder, N. H., de Leij, L.
Publicado 1994

Acute and cumulative effects of carboplatin on renal function.

por Sleijfer, D. T., Smit, E. F., Meijer, S., Mulder, N. H., Postmus, P. E.
Publicado 1989

InterProScan: protein domains identifier

por Quevillon, E., Silventoinen, V., Pillai, S., Harte, N., Mulder, N., Apweiler, R., Lopez, R.
Publicado 2005

5612560 A MONITORING AND EVALUATION FRAMEWORK AND ASSOCIATED TOOLS FOR THE SICKLEINAFRICA CONSORTIUM

por Nembaware, V., Paidamoyo Bodzo, M., Nkanyemka, M., Minja, I., Makani, J., Mulder, N., Wonkam, A.
Publicado 2023

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.

por Mulder, N. H., Willemse, P. H., Schraffordt Koops, H., de Vries, E. G., Sleijfer, D. T.
Publicado 1990

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.

por Meijer, C., Mulder, N. H., Hospers, G. A., Uges, D. R., de Vries, E. G.
Publicado 1990

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.

por Mulder, N. H., de Vries, E. G., Sleijfer, D. T., Schraffordt Koops, H., Willemse, P. H.
Publicado 1992

Peripheral blood lymphocyte number and phenotype prior to therapy correlate with response in subcutaneously applied rIL-2 therapy of renal cell carcinoma.

por Janssen, R. A., Sleijfer, D. T., Heijn, A. A., Mulder, N. H., The, T. H., de Leij, L.
Publicado 1992

Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.

por de Jong, R. S., Slijfer, E. A., Uges, D. R., Mulder, N. H., de Vries, E. G.
Publicado 1997

Phase I study of 21 days continuous infusion with vindesine.

por de Vries, E. G., Smit, E. F., Vendrig, D. E., Holthuis, J. J., Mulder, N. H.
Publicado 1989

Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.

por Martens, A., Janssen, R. A., Sleijfer, D. T., Heijn, A. A., Mulder, N. H., The, T. H., de Leij, L.
Publicado 1993

Survival of non-Western first generations immigrants with stomach cancer in North East Netherlands

por Siemerink, E J M, van der Aa, M A, Siesling, S, Hospers, G A P, Mulder, N H
Publicado 2011

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.

por Mulder, P. O., de Vries, E. G., Uges, D. R., Scaf, A. H., Sleijfer, D. T., Mulder, N. H.
Publicado 1990

Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

por Mulder, N. H., van der Graaf, W. T., Willemse, P. H., Koops, H. S., de Vries, E. G., Sleijfer, D. T.
Publicado 1994

Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.

por Sleijfer, S., Willemse, P. H., de Vries, E. G., van der Graaf, W. T., Schraffordt Koops, H., Mulder, N. H.
Publicado 1996